A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Heart Failure Reviews

• Publication date

  2014-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10741-013-9417-4PMID 24366330
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nebivolol Induces Distinct Changes in Profibrosis MicroRNA Expression Compared With Atenolol, in Salt-Sensitive Hypertensive Rats

  2013cited by this paper
• Specific interactions between Epac1, β-arrestin2 and PDE4D5 regulate β-adrenergic receptor subtype differential effects on cardiac hypertrophic signaling.

  2013cited by this paper
• Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension.

  2013cited by this paper
• Role of Mitogen-Activated Protein Kinase Pathways in Multifactorial Adverse Cardiac Remodeling Associated with Metabolic Syndrome

  2013cited by this paper
• Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase.

  2012influential reference
• Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling.

  2012cited by this paper
• Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients

  2012cited by this paper
• Beta-adrenoceptor signaling pathways mediate cardiac pathological remodeling.

  2012cited by this paper
• Involvement of ERK-RSK cascade in phenylephrine-induced phosphorylation of GATA4.

  2012cited by this paper
• Beta-adrenoceptor regulates miRNA expression in rat heart

  2012cited by this paper
• A randomized controlled phase IIb trial of beta(1)-receptor blockade for chronic degenerative mitral regurgitation.

  2012cited by this paper
• β-Adrenergic Receptor-PI3K Signaling Crosstalk in Mouse Heart: Elucidation of Immediate Downstream Signaling Cascades

  2011cited by this paper
• Capture of MicroRNA–Bound mRNAs Identifies the Tumor Suppressor miR-34a as a Regulator of Growth Factor Signaling

  2011cited by this paper
• Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy.

  2011cited by this paper
• Carvedilol administration in acute myocardial infarction results in stronger inhibition of early markers of left ventricular remodeling than metoprolol.

  2011cited by this paper
• Transforming growth factor (TGF)-β signaling in cardiac remodeling.

  2011cited by this paper
• MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression

  2011cited by this paper
• MicroRNA Expression Analysis: Clinical Advantage of Propranolol Reveals Key MicroRNAs in Myocardial Infarction

  2011cited by this paper
• Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities

  2010cited by this paper
• [Experimental therapy of penehyclidine hydrochloride on paraquat-induced acute lung injury].

  2010cited by this paper
• Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway.

  2010cited by this paper
• Ligand‐directed signalling at β‐adrenoceptors

  2010cited by this paper
• eNOS phosphorylation in health and disease.

  2010cited by this paper
• Constitutive glycogen synthase kinase-3α/β activity protects against chronic β-adrenergic remodelling of the heart

  2010cited by this paper
• Loss of PI3K&ggr; Enhances cAMP-Dependent MMP Remodeling of the Myocardial N-Cadherin Adhesion Complexes and Extracellular Matrix in Response to Early Biomechanical Stress

  2010cited by this paper
• Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data

  2010cited by this paper
• cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action

  2010cited by this paper
• PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer

  2010cited by this paper
• Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

  2010cited by this paper
• Nebivolol Improves Diastolic Dysfunction and Myocardial Remodeling Through Reductions in Oxidative Stress in the Zucker Obese Rat

  2010cited by this paper
• FoxO, Autophagy, and Cardiac Remodeling

  2010cited by this paper
• COMBODY: one‐domain antibody multimer with improved avidity

  2010cited by this paper
• microRNA: a master regulator of cellular processes for bioengineering systems.

  2010cited by this paper
• Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-clip hypertension.

  2010cited by this paper
• The selectivity of β‐adrenoceptor agonists at human β1‐, β2‐ and β3‐adrenoceptors

  2010cited by this paper
• GSK-3alpha directly regulates beta-adrenergic signaling and the response of the heart to hemodynamic stress in mice.

  2010cited by this paper
• STAT3 and cardiac remodeling

  2010cited by this paper
• miRTarBase: a database curates experimentally validated microRNA–target interactions

  2010cited by this paper
• Critical Role of Transcription Factor Cyclic AMP Response Element Modulator in &bgr;1-Adrenoceptor–Mediated Cardiac Dysfunction

  2009cited by this paper
• MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection.

  2009cited by this paper
• Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).

  2009cited by this paper
• The CaV3.2 T-Type Ca2+ Channel Is Required for Pressure Overload–Induced Cardiac Hypertrophy in Mice

  2009cited by this paper
• cGMP regulated protein kinases (cGK).

  2009cited by this paper
• Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor.

  2009cited by this paper
• Physical and Functional Interaction Between Calcineurin and the Cardiac L-Type Ca2+ Channel

  2009cited by this paper
• Effects of the beta3-adrenergic agonist BRL 37344 on endothelial nitric oxide synthase phosphorylation and force of contraction in human failing myocardium.

  2009cited by this paper
• β-Adrenergic stimulation and myocardial function in the failing heart

  2009cited by this paper
• Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta

  2009cited by this paper
• Effects of AT1‐ and β‐adrenergic receptor antagonists on TGF‐β1‐induced fibrosis in transgenic mice

  2009cited by this paper
• The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload

  2009cited by this paper
• The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.

  2008cited by this paper
• Epac Mediates &bgr;-Adrenergic Receptor–Induced Cardiomyocyte Hypertrophy

  2008cited by this paper
• Distinct roles of GSK-3α and GSK-3β phosphorylation in the heart under pressure overload

  2008cited by this paper
• Phosphatases at the heart of FoxO metabolic control.

  2008cited by this paper
• Regulating gene transcription in response to cyclic AMP elevation.

  2008cited by this paper
• Intracellular mechanisms of specific beta-adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure.

  2008cited by this paper
• Atenolol Is Inferior to Metoprolol in Improving Left Ventricular Function and Preventing Ventricular Remodeling in Dogs with Heart Failure

  2008cited by this paper
• Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription.

  2008cited by this paper
• MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets.

  2008cited by this paper
• Small GTP-binding proteins and their regulators in cardiac hypertrophy.

  2008cited by this paper
• Human Protein Reference Database—2009 update

  2008cited by this paper
• Reversal of Systemic Hypertension-Associated Cardiac Remodeling in Chronic Pressure Overload Myocardium by Ciglitazone

  2007cited by this paper
• Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise.

  2007cited by this paper
• Activation of CaMKIIδC Is a Common Intermediate of Diverse Death Stimuli-induced Heart Muscle Cell Apoptosis*

  2007cited by this paper
• Effect of β-Blockers on β3-Adrenoceptor Expression in Chronic Heart Failure

  2007cited by this paper
• Inhibition of p38 alpha MAPK rescues cardiomyopathy induced by overexpressed beta 2-adrenergic receptor, but not beta 1-adrenergic receptor.

  2007cited by this paper
• A novel signaling pathway for beta-adrenergic receptor-mediated activation of phosphoinositide 3-kinase in H9c2 cardiomyocytes.

  2007cited by this paper
• Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection.

  2007cited by this paper
• β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection

  2007cited by this paper
• Effect of beta-blockers on beta3-adrenoceptor expression in chronic heart failure.

  2007cited by this paper
• Glycogen Synthase Kinase-3α Reduces Cardiac Growth and Pressure Overload-induced Cardiac Hypertrophy by Inhibition of Extracellular Signal-regulated Kinases*

  2007cited by this paper
• Rho-kinase phosphorylates eNOS at threonine 495 in endothelial cells.

  2007cited by this paper
• Inhibition of p38α MAPK rescues cardiomyopathy induced by overexpressed β2-adrenergic receptor, but not β1-adrenergic receptor

  2007cited by this paper
• Foxo Transcription Factors Blunt Cardiac Hypertrophy by Inhibiting Calcineurin Signaling

  2006cited by this paper
• Targeted Deletion of Matrix Metalloproteinase 2 Ameliorates Myocardial Remodeling in Mice With Chronic Pressure Overload

  2006cited by this paper
• Beta3-adrenergic eNOS stimulation in left ventricular murine myocardium.

  2006cited by this paper
• Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes.

  2006cited by this paper
• TRPC3 and TRPC6 are essential for angiotensin II‐induced cardiac hypertrophy

  2006cited by this paper
• Epac proteins: multi-purpose cAMP targets.

  2006cited by this paper
• TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling.

  2006cited by this paper
• Noncanonical cAMP pathway and p38 MAPK mediate beta2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts.

  2006cited by this paper
• The selectivity of β‐adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors

  2005cited by this paper
• The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly.

  2005cited by this paper
• The Enigma of β2-Adrenergic Receptor Gi Signaling in the Heart: The Good, the Bad, and the Ugly

  2005cited by this paper
• Effect of β-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats

  2005cited by this paper
• Human protein reference database—2006 update

  2005cited by this paper
• Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice.

  2005cited by this paper
• The FOXO3a Transcription Factor Regulates Cardiac Myocyte Size Downstream of AKT Signaling*

  2005cited by this paper
• Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats.

  2005cited by this paper
• β-Adrenoceptors, but not α-adrenoceptors, stimulate AMP-activated protein kinase in brown adipocytes independently of uncoupling protein-1

  2005cited by this paper
• Drugs for left ventricular remodeling in heart failure.

  2005cited by this paper
• The Biology of Cyclic GMP-dependent Protein Kinases*

  2005cited by this paper
• cAMP-Binding Protein Epac Induces Cardiomyocyte Hypertrophy

  2005cited by this paper
• The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.

  2005cited by this paper
• Beta-adrenoceptors, but not alpha-adrenoceptors, stimulate AMP-activated protein kinase in brown adipocytes independently of uncoupling protein-1.

  2005cited by this paper
• Cardiac oxidative stress in acute and chronic isoproterenol-infused rats.

  2005cited by this paper
• Targeted Activation of c-Jun N-terminal Kinase in Vivo Induces Restrictive Cardiomyopathy and Conduction Defects*[boxs]

  2004cited by this paper
• Role of Osteopontin in Cardiac Fibrosis and Remodeling in Angiotensin II–Induced Cardiac Hypertrophy

  2004cited by this paper
• Involvement of ASK1 in Ca2+‐induced p38 MAP kinase activation

  2004cited by this paper
• Phosphatidylinositol 3-Kinase Offsets cAMP-Mediated Positive Inotropic Effect via Inhibiting Ca2+ Influx in Cardiomyocytes

  2004cited by this paper

• Pharmacological interventions targeting β-adrenoceptors in colorectal cancer: an evolving paradigm

  2025cites this paper
• Thymoquinone mitigates cardiac hypertrophy by activating adaptive autophagy via the PPAR-γ/14-3-3γ pathway

  2025cites this paper
• A contemporary review on heart failure with improved ejection fraction

  2025cites this paper
• Bridging Cancer and Cardiovascular Health: A Comprehensive Review of Cardiotoxicity in Modern Oncology

  2025cites this paper
• Left Ventricular Remodeling After Myocardial Infarction—Pathophysiology, Diagnostic Approach and Management During Cardiac Rehabilitation

  2025cites this paper
• Single-cell insights: pioneering an integrated atlas of chromatin accessibility and transcriptomic landscapes in diabetic cardiomyopathy

  2024cites this paper
• A novel vaccine targeting β1-adrenergic receptor

  2023cites this paper
• 6-Nitrodopamine Is the Most Potent Endogenous Positive Inotropic Agent in the Isolated Rat Heart

  2023cites this paper
• Molecular Aspects Implicated in Dantrolene Selectivity with Respect to Ryanodine Receptor Isoforms

  2023cites this paper
• Preventive use of beta-blockers for anthracycline-induced cardiotoxicity: A network meta-analysis

  2022cites this paper
• The Role of miRNAs in the Resistance of Anthracyclines in Breast Cancer: A Systematic Review

  2022cites this paper
• Effect of β‐blocker on patients with moderate functional mitral regurgitation undergoing surgical aortic valve replacement

  2022influential citation
• Beta receptor blocker therapy for the elderly in the COVID-19 era

  2022cites this paper
• Treatment of glaucoma by prostaglandin agonists and beta‐blockers in combination directly reduces pro‐fibrotic gene expression in trabecular meshwork

  2020cites this paper
• Effects of ambient ozone exposure on circulating extracellular vehicle microRNA levels in coronary artery disease patients

  2020cites this paper
• Cardiac Remodeling: The Course Towards Heart Failure-II. Diagnostic and Therapeutic Approaches

  2019cites this paper
• A Light Wand to Untangle the Myocardial Cell Network

  2019cites this paper
• Association between Sympathetic Nervous System Activation, Obesity and Insulin Resistance

  2019cites this paper
• MicroRNA‐133 suppresses ZFHX3‐dependent atrial remodelling and arrhythmia

  2019cites this paper
• 2,5-Dimethylcelecoxib prevents isoprenaline-induced cardiomyocyte hypertrophy and cardiac fibroblast activation by inhibiting Akt-mediated GSK-3 phosphorylation.

  2019cites this paper
• The progress and controversial of the use of beta blockers in patients with heart failure with a preserved ejection fraction

  2019cites this paper
• Carotid baroreceptor stimulation improves cardiac performance and reverses ventricular remodelling in canines with pacing‐induced heart failure

  2019cites this paper
• Cardiac Remodeling: The Course Toward Heart Failure – I. General Concepts

  2019cites this paper
• Worksite hypertension as a model of stress-induced arterial hypertension.

  2018cites this paper
• 3D and 4D Bioprinting of the Myocardium: Current Approaches, Challenges, and Future Prospects

  2018cites this paper
• High sympathetic tone in development of the left ventricle hypertrophy and beta-blockers for regression

  2018cites this paper
• [Sympathetic Nervous System Activation in Pathogenesis of Development of Essential Hypertension and Its Role in Target-Organs Damage in Young and Middle Aged Adults: the Cardioprotective Capabilities of Bisoprolol].

  2018cites this paper
• ADRB2 polymorphism Arg16Gly modifies the natural outcome of heart failure and dictates therapeutic response to β-blockers in patients with heart failure

  2018cites this paper
• Role of ivabradine and heart rate lowering in chronic heart failure: guideline update

  2018cites this paper
• Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trial.

  2017cites this paper
• Modulation de TREM-1 au cours du l'infarctus du myocarde

  2016cites this paper
• β-Adrenergic response is counteracted by extremely-low-frequency pulsed electromagnetic fields in beating cardiomyocytes.

  2016cites this paper
• Protein kinase A–dependent phosphorylation stimulates the transcriptional activity of hypoxia-inducible factor 1

  2016cites this paper
• Achievement of a target dose of bisoprolol may not be a preferred option for attenuating pressure overload-induced cardiac hypertrophy and fibrosis

  2016cites this paper
• Sarco"MiR" friend or foe: a perspective on the mechanisms of doxorubicin-induced cardiomyopathy.

  2016cites this paper
• Pharmacological Intervention with Atenolol and Diazepam in Seizure-Induced Cardiomyopathy

  2015cites this paper
• Adrenerg stimuláció hatása a szívizomsejtek akciós potenciáljára, és az őket kialakító ionáramokra

  2014cites this paper
• The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases.

  2014cites this paper
• Diabetic Macular Edema

  1969cites this paper